Published :
Tables : 47
Figures : 43
Category : Healthcare
No. of Pages : 220
Report Code : HC-U5499
Remote Patient Monitoring (RPM) Market is poised to register a CAGR of 26.7% during the forecast period 2022 to 2028. Digital technologies are used to convey medical and other sorts of health data, such as clinical data, patient registry, and patient current health status, to a healthcare professional during remote patient monitoring. By gathering the data at the patient's home, money can be saved on care and hospitalisation. The expansion of the remote patient monitoring market share is driven by the growing elderly population and increase in disposable income. Due to the rapidly expanding global population and rise in the prevalence of chronic diseases, there has been an increase in the need to upgrade the healthcare infrastructure, as well as the cost-savings advantages of telehealth and the use of remote patient monitoring technology. The prevalence of lifestyle disorders, increased use of remote patient monitoring devices, and an increase in the number of elderly people are what are driving the expansion of the remote patient monitoring market size. The ease of use and accessibility of remote patient monitoring equipment is helping it become more and more popular. Additionally, elderly people use remote patient devices because they are more likely to have chronic illnesses than younger people. The market is anticipated to grow as a result of the rise in demand for tools used for at-home remote patient monitoring. Global demand for these systems will rise in the coming years due to the improved chronic illness management offered by remote monitoring systems, together with early warning indicators and progress trackers. As the telemedicine software aids in digitising and automating crucial tasks, which minimises hospital administrative work and expands the use of Remote Patient Monitoring in the coming years, it can prevent ER visits and hospitalizations. FutureWise Market Research has instantiated a report that provides an intricate analysis of Remote Patient Monitoring (RPM) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Remote Patient Monitoring (RPM) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Remote Patient Monitoring (RPM) Market: • BioTelemetry Inc. • Koninklijke Philips N.V. • Medtronic • GE Healthcare • Cerner Corporation • Siemens Healthineers AG Germany • OMRON Healthcare • Boston Scientific Corporation • Abbott Laboratories • Resideo Life Care Solutions • Vivify Health, Inc. • ALTEN Calsoft Labs • Preventice Solutions • Bio-Beat Technologies • VitalConnect • Welch Allyn • Teladoc Health Inc. • Dexcom Inc. • iRhythm Technologies, Inc. • VivaLNK Inc. (US). (Note: The list of the major players will be updated with the latest market scenario and trends) Remote Patient Monitoring (RPM) Market Segmentation: By Type • Services & Software • Devices o Cardiac Monitoring Devices o Neurological Monitoring Devices o Respiratory Monitoring Devices o Multiparameter Monitoring Devices o Blood Glucose Monitoring Devices o Fetal & Neonatal Monitoring Devices o Weight Monitoring Devices o Other Monitoring Devices By Application • Cancer Treatment • Cardiovascular Diseases Treatment • Diabetes Treatment • Sleep Disorder Treatment • Weight Management and Fitness Monitoring By End User • Providers o Hospitals and Clinics o Home Care Settings and Long Term Care Centers o Ambulatory Care Centers • Payers • Patients • Other End Users By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Remote Patient Monitoring (RPM) Market Sample Video: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Remote Patient Monitoring (RPM) Market By Type, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Digital technologies are used to convey medical and other sorts of health data, such as clinical data, patient registry, and patient current health status, to a healthcare professional during remote patient monitoring. By gathering the data at the patient's home, money can be saved on care and hospitalisation. The expansion of the remote patient monitoring market share is driven by the growing elderly population and increase in disposable income. Due to the rapidly expanding global population and rise in the prevalence of chronic diseases, there has been an increase in the need to upgrade the healthcare infrastructure, as well as the cost-savings advantages of telehealth and the use of remote patient monitoring technology. The prevalence of lifestyle disorders, increased use of remote patient monitoring devices, and an increase in the number of elderly people are what are driving the expansion of the remote patient monitoring market size. The ease of use and accessibility of remote patient monitoring equipment is helping it become more and more popular. Additionally, elderly people use remote patient devices because they are more likely to have chronic illnesses than younger people. The market is anticipated to grow as a result of the rise in demand for tools used for at-home remote patient monitoring.
Global demand for these systems will rise in the coming years due to the improved chronic illness management offered by remote monitoring systems, together with early warning indicators and progress trackers. As the telemedicine software aids in digitising and automating crucial tasks, which minimises hospital administrative work and expands the use of Remote Patient Monitoring in the coming years, it can prevent ER visits and hospitalizations.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Remote Patient Monitoring (RPM) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Remote Patient Monitoring (RPM) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Remote Patient Monitoring (RPM) Market: • BioTelemetry Inc. • Koninklijke Philips N.V. • Medtronic • GE Healthcare • Cerner Corporation • Siemens Healthineers AG Germany • OMRON Healthcare • Boston Scientific Corporation • Abbott Laboratories • Resideo Life Care Solutions • Vivify Health, Inc. • ALTEN Calsoft Labs • Preventice Solutions • Bio-Beat Technologies • VitalConnect • Welch Allyn • Teladoc Health Inc. • Dexcom Inc. • iRhythm Technologies, Inc. • VivaLNK Inc. (US). (Note: The list of the major players will be updated with the latest market scenario and trends)
Remote Patient Monitoring (RPM) Market Segmentation: By Type • Services & Software • Devices o Cardiac Monitoring Devices o Neurological Monitoring Devices o Respiratory Monitoring Devices o Multiparameter Monitoring Devices o Blood Glucose Monitoring Devices o Fetal & Neonatal Monitoring Devices o Weight Monitoring Devices o Other Monitoring Devices
By Application • Cancer Treatment • Cardiovascular Diseases Treatment • Diabetes Treatment • Sleep Disorder Treatment • Weight Management and Fitness Monitoring
By End User • Providers o Hospitals and Clinics o Home Care Settings and Long Term Care Centers o Ambulatory Care Centers • Payers • Patients • Other End Users
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Remote Patient Monitoring (RPM) Market Sample Video:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Remote Patient Monitoring (RPM) Market By Type, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Remote Patient Monitoring (RPM) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Remote Patient Monitoring (RPM) Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Remote Patient Monitoring (RPM) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Remote Patient Monitoring (RPM) Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Services & Software 7.2. Devices 7.2.1. Cardiac Monitoring Devices 7.2.2. Neurological Monitoring Devices 7.2.3. Respiratory Monitoring Devices 7.2.4. Multiparameter Monitoring Devices 7.2.5. Blood Glucose Monitoring Devices 7.2.6. Fetal & Neonatal Monitoring Devices 7.2.7. Weight Monitoring Devices 7.2.8. Other Monitoring Devices 8. Remote Patient Monitoring (RPM) Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Cancer Treatment 8.2. Cardiovascular Diseases Treatment 8.3. Diabetes Treatment 8.4. Sleep Disorder Treatment 8.5. Weight Management and Fitness Monitoring 9. Remote Patient Monitoring (RPM) Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Providers 9.1.1. Hospitals and Clinics 9.1.2. Home Care Settings and Long Term Care Centers 9.1.3. Ambulatory Care Centers 9.2. Payers 9.3. Patients 9.4. Other End Users 10. North America Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. BioTelemetry Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Koninklijke Philips N.V. 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medtronic 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. GE Healthcare 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Cerner Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Siemens Healthineers AG Germany 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. OMRON Healthcare 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Boston Scientific Corporation 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Abbott Laboratories 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Resideo Life Care Solutions 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. Vivify Health, Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. ALTEN Calsoft Labs 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13. Preventice Solutions 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14. Bio-Beat Technologies 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 15.15. VitalConnect 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16. Welch Allyn 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17. Teladoc Health Inc. 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18. Dexcom Inc. 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19. iRhythm Technologies, Inc. 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20. VivaLNK Inc 16.20.1. Company Overview 16.20.2. Product Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Remote Patient Monitoring (RPM) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Remote Patient Monitoring (RPM) Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Remote Patient Monitoring (RPM) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Remote Patient Monitoring (RPM) Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Services & Software 7.2. Devices 7.2.1. Cardiac Monitoring Devices 7.2.2. Neurological Monitoring Devices 7.2.3. Respiratory Monitoring Devices 7.2.4. Multiparameter Monitoring Devices 7.2.5. Blood Glucose Monitoring Devices 7.2.6. Fetal & Neonatal Monitoring Devices 7.2.7. Weight Monitoring Devices 7.2.8. Other Monitoring Devices
8. Remote Patient Monitoring (RPM) Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Cancer Treatment 8.2. Cardiovascular Diseases Treatment 8.3. Diabetes Treatment 8.4. Sleep Disorder Treatment 8.5. Weight Management and Fitness Monitoring
9. Remote Patient Monitoring (RPM) Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Providers 9.1.1. Hospitals and Clinics 9.1.2. Home Care Settings and Long Term Care Centers 9.1.3. Ambulatory Care Centers 9.2. Payers 9.3. Patients 9.4. Other End Users
10. North America Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. BioTelemetry Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Koninklijke Philips N.V. 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medtronic 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. GE Healthcare 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Cerner Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Siemens Healthineers AG Germany 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. OMRON Healthcare 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Boston Scientific Corporation 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Abbott Laboratories 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Resideo Life Care Solutions 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. Vivify Health, Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. ALTEN Calsoft Labs 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13. Preventice Solutions 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14. Bio-Beat Technologies 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 15.15. VitalConnect 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16. Welch Allyn 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17. Teladoc Health Inc. 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.18. Dexcom Inc. 16.18.1. Company Overview 16.18.2. Product Portfolio 16.18.3. SWOT Analysis 16.18.4. Financial Overview 16.18.5. Strategic Overview 16.19. iRhythm Technologies, Inc. 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20. VivaLNK Inc 16.20.1. Company Overview 16.20.2. Product Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics